Regeneron Says Otarmeni Application Accepted Under EU Accelerated Assessment
[출처/시간] MT Newswires - 7:38 AM ET, 05/22/2026 07:38 AM EDT, 05/22/2026 (MT Newswires) -- Regeneron Pharmaceuticals (REGN) said Friday the European Medicines Agency has accepted for accelerated assessment its marketing authorization application for Otarmeni to treat OTOF-related hearing loss. Th...
[출처/시간] MT Newswires - 7:38 AM ET, 05/22/2026
07:38 AM EDT, 05/22/2026 (MT Newswires) -- Regeneron Pharmaceuticals (REGN) said Friday the European Medicines Agency has accepted for accelerated assessment its marketing authorization application for Otarmeni to treat OTOF-related hearing loss. Th...
당신의 반응은 무엇인가요?
좋아요
0
싫어요
0
사랑
0
재미있는
0
화난
0
슬프다
0
와우
0
